1. A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA). Issue 4 (April 2019) Authors: Bischoff, Joachim; Barinoff, Jana; Mundhenke, Christoph; Bauerschlag, Dirk O.; Costa, Serban-Dan; Herr, Daniel; Lübbe, Kristina; Marmé, Frederik; Maass, Nicolai; von Minckwitz, Gunter; Grischke, Eva-Maria; Müller, Volkmar; Schmidt, Marcus; Gerber, Bernd; Kümmel, Sherko; Schumacher, Claudia; Krabi... Journal: Anti-cancer drugs Issue: Volume 30:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chemotherapy-induced ovarian failure in young women with early breast cancer: Prospective analysis of four randomised neoadjuvant/adjuvant breast cancer trials. (July 2021) Authors: Furlanetto, Jenny; Marmé, Frederik; Seiler, Sabine; Thode, Christian; Untch, Michael; Schmatloch, Sabine; Schneeweiss, Andreas; Bassy, Martina; Fasching, Peter A.; Strik, Dominika; Stickeler, Elmar; Schem, Christian; Karn, Thomas; Grischke, Eva-Maria; Denkert, Carsten; van Mackelenbergh, Marion; ... Journal: European journal of cancer Issue: Volume 152(2021) Page Start: 193 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical and molecular characteristics of HER2-low-positive breast cancer: pooled analysis of individual patient data from four prospective, neoadjuvant clinical trials. Issue 8 (August 2021) Authors: Denkert, Carsten; Seither, Fenja; Schneeweiss, Andreas; Link, Theresa; Blohmer, Jens-Uwe; Just, Marianne; Wimberger, Pauline; Forberger, Almuth; Tesch, Hans; Jackisch, Christian; Schmatloch, Sabine; Reinisch, Mattea; Solomayer, Erich F; Schmitt, Wolfgang D; Hanusch, Claus; Fasching, Peter A; Lübb... Journal: Lancet oncology Issue: Volume 22:Issue 8(2021) Page Start: 1151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Locoregional recurrence risk after neoadjuvant chemotherapy: A pooled analysis of nine prospective neoadjuvant breast cancer trials. (May 2020) Authors: Werutsky, Gustavo; Untch, Michael; Hanusch, Claus; Fasching, Peter A.; Blohmer, Jens-Uwe; Seiler, Sabine; Denkert, Carsten; Tesch, Hans; Jackisch, Christian; Gerber, Bernd; Schneeweiss, Andreas; Link, Theresa; Krug, David; Huober, Jens; Rhiem, Kerstin; Kühn, Thorsten; Vladimirova, Valentina; Nekl... Journal: European journal of cancer Issue: Volume 130(2020) Page Start: 92 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Outcome of breast cancer patients treated with chemotherapy during pregnancy compared with non-pregnant controls. (July 2022) Authors: Amant, Frédéric; Nekljudova, Valentina; Maggen, Charlotte; Seither, Fenja; Neven, Patrick; Cardonick, Elyce H.; Schmatloch, Sabine; Van Calsteren, Kristel; Cordes, Tatjana; de Haan, Jorine; Lok, Christianne A.R.; Flock, Felix; Boere, Ingrid A.; Gziri, Mina M.; Solbach, Christine; Lefrère, Hanne; ... Journal: European journal of cancer Issue: Volume 170(2022) Page Start: 54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial. Issue 14 (10th May 2021) Authors: Loibl, Sibylle; Marmé, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Hervé; Kim, Sung-Bae; Bear, Harry; McCarthy, Nicole; Melé Olivé, Mireia; Gelmon, Karen; García-Sáenz, José; Kelly, Catherine M.; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S.; Denkert, Carsten; Gnant, Michael; Makris, Andre... Journal: Journal of clinical oncology Issue: Volume 39:Issue 14(2021) Page Start: 1518 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Subcutaneous injection of trastuzumab into the thigh versus abdominal wall in patients with HER2-positive early breast cancer: Pharmacokinetic, safety and patients' preference - Substudy of the randomised phase III GAIN-2 study. (December 2022) Authors: Reinisch, Mattea; Untch, Michael; Mahlberg, Rolf; Reimer, Toralf; Hitschold, Thomas; Marmé, Frederik; Aydogdu, Mustafa; Schmatloch, Sabine; Lück, Hans-Joachim; Schmidt, Marcus; Ladda, Ekkehart; Sinn, Bruno Valentin; Klare, Peter; Janni, Wolfgang; Jackisch, Christian; Denkert, Carsten; Seiler, Sab... Journal: Breast Issue: Volume 66(2022) Page Start: 110 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗